Updated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B

S. Yuki, K. Shinozaki, T. Kashiwada, T. Kusumoto, M. Iwatsuki, H. Satake, S. Tokunaga, Y. Emi, A. Makiyama, Y. Kawamoto, Y. Komatsu, M. Shimokawa, H. Saeki, E. Oki, H. Baba, Y. Maehara

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii225
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this